European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
Franz Trautinger, Robert Knobler(Medical University of Vienna), Nicola Pimpinelli(University of Florence), Chalid Assaf(MSH Medical School Hamburg – University of Applied Sciences and Medical University), Pablo L. Ortiz‐Romero(Hospital Universitario 12 De Octubre), Pietro Quaglino(Department of Medical Sciences), Evangelia Papadavid(National and Kapodistrian University of Athens), M. Bagot(Inserm), Rein Willemze(Leiden University Medical Center), Annamari Ranki(University of Helsinki), Julia Scarisbrick(University Hospital of Zurich), Maarten H. Vermeer(Leiden University Medical Center), Liisa Väkevä(Helsinki University Hospital), Reinhard Dummer(University Hospital of Zurich), Sean Whittaker(Guy's Hospital), Antonio Cozzio(Ostschweizer Kinderspital), Johanna Eder(Karl Landsteiner University of Health Sciences), Rudolf Stadler(University Hospitals of the Ruhr-University of Bochum), Claus‐Detlev Klemke(Städtisches Klinikum Karlsruhe), Robert Gniadecki(University of Alberta)
Cited by 449
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma
|New England Journal of Medicine|2017|1.5k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k